US healthcare spending neared $5 trillion in 2023, government report says
Adds spending details from report, CMS official's comment, background, paragraphs 3-11
By Amina Niasse
NEW YORK, Dec 18 (Reuters) -U.S. healthcare spending rose by 7.5% to $4.9 trillion in 2023, driven by increased use of medical services as enrollment climbed for private health plans, particularly those under the Affordable Care Act, the Centers for Medicare and Medicaid Services said in a report on Wednesday.
The agency, which oversees Medicare plans for people aged 65 and older or with disabilities, said healthcare spending outpaced U.S. economic growth. It rose by an inflation-adjusted 4.4% compared with gross domestic product growth of 2.9% in 2023, the report said.
Spending on retail prescription drugs had the biggest increase, rising 11.4% to $449.7 billion after a 7.8% rise in 2022, largely due to the use of weight-loss and diabetes drugs, a CMS official said during a press briefing.
Within the Medicare prescription drug benefit, the amount spent on diabetes medicines like the popular newer GLP-1 medicines such as Novo Nordisk's NOVOb.CO Ozempic and Wegovy that are also used for weight loss, increased 35%, the official said.
"That significantly contributed to Medicare prescription drug spending growth of 12.2%," the official added.
Healthcare represented 17.6% of the U.S. economy in 2023, slightly up from 17.4% in 2022. That portion is slightly lower than at the height of the COVID-19 pandemic, the report said.
Spending for hospital care services totaled $1.5 trillion in 2023, rising by 10.4%, the highest growth in nearly three decades. Spending on clinical services increased 7.4%.
Commercial insurers represented the largest share of spending, jumping to 30% from 19.5% in 2022, due to increased enrollment in employer-sponsored health plans and greater enrollment in ACA plans, commonly referred to as Obamacare.
The 2021 American Rescue Plan Act and 2022 Inflation Reduction Act included enhanced subsidies that reduced the cost of premiums for people enrolled in Obamacare plans. Following introduction of those policies, 2.7 million additional people signed up for Obamacare plans in 2023.
Enrollment in private health insurance increased 1.6% in 2023, representing 3.3 million Americans, CMS said.
The report found that 92.5% of Americans were covered by some form of health insurance in 2023, up from 92.0% in 2022.
Reporting by Amina Niasse; editing by Caroline Humer and Bill Berkrot
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
